Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 3-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists

3-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists

US Patent 8106232 · Granted Jan 31, 2012

Estimated economic value: $8,049,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted benzenecarboxamides as IL-17A modulators2025
Dimethyl amino azetidine amides as JAK inhibitors2025
Crystalline (2S,4R)-5-(5'-chloro-2'-fluoro-[1,1'-biphenyl]-4-yl)-2-(ethoxymethyl2025
Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compound2025
IL-17 ligands and uses thereof2025
Substituted 4-phenyl pyridine compounds as non-systemic TGR5 agonists2024
Compounds and methods for inhibiting NHE-mediated antiport in the treatment of d2024
Combination of a PD-1 antagonist and CpG-C type oligonucleotide for treating can2024
Prodrugs of fencamfamine2024
Glycyrrhetinic acid derivatives for use in treating hyperkalemia2024
Ester and carbonate pyrimidine compounds as JAK kinase inhibitors2023
Glycyrrhetinic acid derivatives for treating hyperkalemia2023